NCT03246035

Brief Summary

A randomized study designed to determine whether telephone based interventions can prevent return hospital visits for elderly and frail patients with acute symptoms of heart failure. Specifically, the intervention will improve patients ability to monitor and address self care of heart failure at home.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 11, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

October 14, 2022

Status Verified

October 1, 2022

Enrollment Period

3 years

First QC Date

June 28, 2017

Last Update Submit

October 12, 2022

Conditions

Keywords

Acute Decompensated Heart FailureHeart FailureFrailtyGeriatricsSelf-careEmergency MedicineCardiologyPatient Oriented Research

Outcome Measures

Primary Outcomes (1)

  • All-cause death, hospital readmission, or ED revisit

    90 days

Secondary Outcomes (10)

  • Rate of return visits to any ER for any medical issue

    30 days

  • Rate of admission to hospital at 90 days

    90 days

  • Incidence of adverse effects from medication

    90 days

  • Self-Care Index

    90 days

  • Heart Failure Symptom Scale

    90 days

  • +5 more secondary outcomes

Study Arms (2)

Control Group (Standard Care)

ACTIVE COMPARATOR

The control group will receive outpatient follow-up, medication advice and lifestyle guidance as prescribed at discharge from the ED or hospital.

Other: Control Group (Standard Care)

Intervention Group

EXPERIMENTAL

The intervention will consist of contacting the patient 5 days post-discharge and arranging definitive outpatient follow-up and providing targeted medical and lifestyle advice based on deficient domains identified at baseline.

Behavioral: Intervention Group

Interventions

For the intervention arm, a specialized heart failure nurse practitioner will contact the patient or their primary caregiver by telephone within 5 days post-discharge and send them an education packet by mail. During the telephone call, the nurse will (1) confirm the patient's scheduled follow-up appointment in cardiology, (2) provide recommendations for heart failure self-care behaviors that were found to be deficient at baseline. Patients will then be referred to a Geriatrics Assessment Team, who will provide individualized recommendations for frailty domains that were found to be deficient at baseline. The technique used to provide educational recommendations will be motivational interviewing.

Intervention Group

For patients randomized to the Control Group (Standard Care), they will receive their follow-up visits, medications, diet and physical activity advice as they normally would. This is the care they would receive even if they were not enrolled in the study

Control Group (Standard Care)

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients who presented to the ED and who are being discharged with a primary or secondary diagnosis of ADHF
  • Age ≥ 65
  • Frailty, defined as a FRAIL score \>=3/5 or Clinical Frailty Scale (CFS) score \>=5/9
  • Informed consent provided by the patient or proxy

You may not qualify if:

  • Significant dementia or active delirium
  • Severe frailty, defined as a CFS score \>=8/9
  • Prohibitive language barrier
  • Primary address outside of Quebec
  • Patient deemed to be palliative or moribund by treating team

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Location

MeSH Terms

Conditions

Heart FailureEmergenciesFrailty

Interventions

Control GroupsStandard of Care

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethodsQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Jonathan Afilalo, FRCPC

    Associate Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

June 28, 2017

First Posted

August 11, 2017

Study Start

March 1, 2018

Primary Completion

March 1, 2021

Study Completion

March 1, 2022

Last Updated

October 14, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Available IPD Datasets

Study Protocol (CODIM-MBM-17-052)Access
Informed Consent Form (CODIM-MBM-17-052)Access

Locations